Aptevo Therapeutics (APVO) Asset Utilization Ratio (2016 - 2022)
Aptevo Therapeutics (APVO) posted Asset Utilization Ratio of 0.09 for Q4 2022, down 50.87% sequentially from 0.19 in Q3 2022, and down 53.64% YoY from 0.2 in Q4 2021.
Aptevo Therapeutics (APVO) Asset Utilization Ratio (2016 - 2022) Analysis & Trends
Aptevo Therapeutics has reported Asset Utilization Ratio for 7 years, with the latest figure at 0.09 in Q4 2022.
- Quarterly Asset Utilization Ratio fell 53.64% year-over-year to 0.09 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 0.09 (down 53.64% YoY) and the FY2022 annual result came in at 0.07, down 69.27% from the prior year.
- Asset Utilization Ratio fell to 0.09 in Q4 2022 per APVO's latest filing, from 0.19 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 1.18 in Q2 2020 and troughed at 0.09 in Q4 2022.
- A 5-year average of 0.37 and a median of 0.26 in 2022 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2019 and 2021: Asset Utilization Ratio soared 256.28% in 2019, then sank 88.7% in 2021.
- Over 5 years, Asset Utilization Ratio stood at 0.45 in 2018, then grew by 26.95% to 0.57 in 2019, then sank by 48.46% to 0.29 in 2020, then plunged by 30.5% to 0.2 in 2021, then sank by 53.64% to 0.09 in 2022.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.09, 0.19, and 0.24 for Q4 2022, Q3 2022, and Q2 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.13 |
| 10 | Aptevo Therapeutics | 3.19 Mn | -6.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.09 |
| Sep 30, 2022 | 0.19 |
| Jun 30, 2022 | 0.24 |
| Mar 31, 2022 | 0.26 |
| Dec 31, 2021 | 0.20 |
| Sep 30, 2021 | 0.16 |
| Jun 30, 2021 | 0.13 |
| Mar 31, 2021 | 0.11 |
| Dec 31, 2020 | 0.29 |
| Sep 30, 2020 | 0.71 |
| Jun 30, 2020 | 1.18 |
| Dec 31, 2019 | 0.57 |
| Sep 30, 2019 | 0.63 |
| Jun 30, 2019 | 0.57 |
| Mar 31, 2019 | 0.52 |
| Sep 30, 2018 | 0.45 |
| Jun 30, 2018 | 0.26 |
| Mar 31, 2018 | 0.15 |
| Sep 30, 2017 | 0.19 |
| Jun 30, 2017 | 0.19 |